| Literature DB >> 30356715 |
Fernando M Alferez1,2, Kayla M Gerberich1, Jian-Liang Li3, Yanping Zhang4, James H Graham1, Zhonglin Mou5.
Abstract
Nicotinamide adenine dinucleotide (NAD) is a universal electron carrier that participates in important intracellular metabolic reactions and signaling events. Interestingly, emerging evidence in animals indicates that cellular NAD can be actively or passively released into the extracellular space, where it is processed or perceived by ectoenzymes or cell-surface receptors. We have recently shown in Arabidopsis thaliana that exogenous NAD induces defense responses, that pathogen infection leads to release of NAD into the extracellular space at concentrations sufficient for defense activation, and that depletion of extracellular NAD (eNAD) by transgenic expression of the human NAD-hydrolyzing ectoenzyme CD38 inhibits plant immunity. We therefore hypothesize that, during plant-microbe interactions, NAD is released from dead or dying cells into the extracellular space where it interacts with adjacent naïve cells' surface receptors, which in turn activate downstream immune signaling. However, it is currently unknown whether eNAD signaling is unique to Arabidopsis or the Brassicaceae family. In this study, we treated citrus plants with exogenous NAD+ and tested NAD+-induced transcriptional changes and disease resistance. Our results show that NAD+ induces profound transcriptome changes and strong resistance to citrus canker, a serious citrus disease caused by the bacterial pathogen Xanthomonas citri subsp. citri (Xcc). Furthermore, NAD+-induced resistance persists in new flushes emerging after removal of the tissues previously treated with NAD+. Finally, NAD+ treatment primes citrus tissues, resulting in a faster and stronger induction of multiple salicylic acid pathway genes upon subsequent Xcc infection. Taken together, these results indicate that exogenous NAD+ is able to induce immune responses in citrus and suggest that eNAD may also be an elicitor in this woody plant species.Entities:
Keywords: Citrus sinensis; Xanthomonas citri subsp. citri; citrus canker; defense gene; disease resistance; extracellular NAD; transcriptional changes
Year: 2018 PMID: 30356715 PMCID: PMC6189366 DOI: 10.3389/fpls.2018.01472
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Possible defense-related genes that were induced by NAD+ treatment.
| Probeset ID | NAD+/Water | Transcript ID | Target description | |
|---|---|---|---|---|
| Log2(FC) | ||||
| Cit.12743.1.S1_at | 3.48 | 0.011 | Cit.12743.1 | Putative glutathione |
| Cit.36935.1.S1_s_at | 2.92 | 0.006 | Cit.36935.1 | |
| Cit.16841.1.S1_at | 2.84 | 0.000 | Cit.16841.1 | NIM-interacting protein 2 (NIMIN2) |
| Cit.2730.1.S1_at | 2.11 | 0.009 | Cit.2730.1 | Mitogen-activated protein kinase |
| Cit.9675.1.S1_at | 1.78 | 0.000 | Cit.9675.1 | Glutathione transferase |
| Cit.14156.1.S1_s_at | 1.76 | 0.008 | Cit.14156.1 | Mitogen-activated protein kinase kinase (MAPKK) 9, putative (MKK9) |
| Cit.36833.1.S1_at | 1.70 | 0.003 | Cit.36833.1 | MATE efflux family protein |
| Cit.16865.1.S1_at | 1.61 | 0.004 | Cit.16865.1 | Thioredoxin H |
| Cit.753.1.S1_x_at | 1.58 | 0.015 | Cit.753.1.S1 | Pathogenesis-related protein 4A (PR4A) |
| Cit.2113.1.S1_at | 1.58 | 0.000 | Cit.2113.1 | Disease resistance-responsive protein-related/dirigent protein-related |
| Cit.21717.1.S1_at | 1.51 | 0.001 | Cit.21717.1 | Pathogenesis-related protein 4b (PR4B) |
| Cit.9293.1.S1_at | 1.48 | 0.003 | Cit.9293.1 | UDP-glucose:salicylic acid glucosyltransferase |
| Cit.2058.1.S1_s_at | 1.44 | 0.000 | Cit.2058.1 | MATE efflux family protein |
| Cit.17342.1.S1_at | 1.43 | 0.003 | Cit.17342.1 | Chorismate mutase, cytosolic (CM2) |
| Cit.18086.1.S1_s_at | 1.42 | 0.027 | Cit.18086.1 | Pathogenesis-related genes transcriptional activator PTI5 |
| Cit.19571.1.S1_s_at | 1.40 | 0.010 | Cit.19571.1 | Disease resistance-responsive protein-related/dirigent protein-related |
| Cit.29252.1.S1_at | 1.29 | 0.048 | Cit.29252.1 | EDS1 |
| Cit.6165.1.S1_at | 1.26 | 0.004 | Cit.6165.1 | Putative MATE efflux protein family protein |
| Cit.25547.1.S1_at | 1.26 | 0.000 | Cit.25547.1 | Leucine-rich repeat receptor-like kinase |
| Cit.29940.1.S1_at | 1.25 | 0.000 | Cit.29940.1 | Protein phosphatase 2C-like protein |
| Cit.25902.1.S1_at | 1.24 | 0.010 | Cit.25902.1 | Glutathione |
| Cit.17645.1.S1_x_at | 1.19 | 0.000 | Cit.17645.1 | Glutathione |
| Cit.3694.1.S1_at | 1.17 | 0.001 | Cit.3694.1 | Putative protein phosphatase 2C |
| Cit.8664.1.S1_x_at | 1.17 | 0.000 | Cit.8664.1 | MATE efflux family protein |
| Cit.2116.1.S1_s_at | 1.17 | 0.024 | Cit.2116.1 | Pathogenesis-related protein 5-1 |
| Cit.17228.1.S1_x_at | 1.16 | 0.022 | Cit.17228.1 | Immediate-early salicylate-induced glucosyltransferase pir |
| Cit.8482.1.S1_x-at | 1.16 | 0.000 | Cit.8482.1 | Glutathione |
| Cit.4233.1.S1_s_at | 1.13 | 0.004 | Cit.4233.1 | Disease resistance protein, putative |
| Cit.34261.1.S1_s_at | 1.12 | 0.000 | Cit.34261.1 | MATE efflux family protein |
| Cit.23245.1.S1_at | 1.09 | 0.007 | Cit.23245.1 | Glutathione |
| Cit.18055.1.S1_s_at | 1.09 | 0.019 | Cit.18055.1 | Putative leucine-rich repeat receptor kinase |
| Cit.356.1.S1_s_at | 1.07 | 0.004 | Cit.356.1 | Thioredoxin H |
| Cit.6308.1.S1_at | 1.07 | 0.037 | Cit.6308.1 | Putative glutathione |
| Cit.6136.1.S1_at | 1.04 | 0.003 | Cit.6136.1 | Bacterial spot disease resistance protein 4 |
| Cit.28421.1.S1_s_at | 1.03 | 0.005 | Cit.28421.1 | Putative cyclic nucleotide and calmodulin-regulated ion channel protein |
| Cit.26653.1.S1_at | 1.01 | 0.003 | Cit.26653.1 | EIX receptor 2 |